Showing results (431-440 of 794) with videos related to
Sort By:
Pageof 80
The New England Journal of Medicine|October 29, 1998
Maintenance antiretroviral therapies in HIV-infected subjects with undetectable plasma HIV RNA after triple-drug therapy. AIDS Clinical Trials Group Study 343 TeamD V Havlir, I C Marschner, M S Hirsch, et al.Topics in Antiviral Medicine|February 17, 2017
A Conversation Among the IAS-USA Board of Directors: Hot Topics and Emerging Data in HIV Research and CareConstance A Benson, Judith S Currier, Carlos Del Rio, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 24, 2001
Immunostimulatory DNA-based vaccines elicit multifaceted immune responses against HIV at systemic and mucosal sitesA A Horner, S K Datta, K Takabayashi, et al.The Journal of Infectious Diseases|February 15, 2001
Productive infection of T cells in lymphoid tissues during primary and early human immunodeficiency virus infectionT Schacker, S Little, E Connick, et al.AIDS (London, England)|December 13, 2002
Multiple measures of HIV burden in blood and tissue are correlated with each other but not with clinical parameters in aviremic subjectsPeter A Anton, Ronald T Mitsuyasu, Steven G Deeks, et al.Journal of Acquired Immune Deficiency Syndromes|January 1, 1992
Characterization of HIV isolates arising after prolonged zidovudine therapyD L Mayers, F E McCutchan, E E Sanders-Buell, et al.The New England Journal of Medicine|January 18, 2013
Enhanced CD4+ T-cell recovery with earlier HIV-1 antiretroviral therapyTuan Le, Edwina J Wright, Davey M Smith, et al.Lancet (London, England)|April 2, 2013
Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirsChristine Katlama, Steven G Deeks, Brigitte Autran, et al.The Journal of Infectious Diseases|May 23, 2014
HIV type 1 (HIV-1) proviral reservoirs decay continuously under sustained virologic control in HIV-1-infected children who received early treatmentKatherine Luzuriaga, Barbara Tabak, Manuel Garber, et al.JAMA|July 13, 2001
Prevalence and predictive value of intermittent viremia with combination hiv therapyD V Havlir, R Bassett, D Levitan, et al.Pageof 80